These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6983863)

  • 21. Reassessment of cefaclor breakpoints for Haemophilus influenzae.
    MacKenzie FM; Milne KE; Gould IM
    J Chemother; 2004 Aug; 16(4):329-33. PubMed ID: 15332705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of cefaclor.
    Derry JE
    Am J Hosp Pharm; 1981 Jan; 38(1):54-8. PubMed ID: 7011003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cefaclor: a contemporary look at susceptibility of key pathogens from around the globe.
    Preston DA; Turik M
    J Chemother; 1998 Jun; 10(3):195-202. PubMed ID: 9669643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A simple disk diffusion test to identify beta-lactamase-negative, ampicillin-resistant Haemophilus influenzae--application of cephalexin, cefsulodin and cefaclor disks].
    Endo R; Yamane N; Tamayose MH; Uchibori KK; Nakasone I
    Rinsho Byori; 2010 Oct; 58(10):963-71. PubMed ID: 21077285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacies of erythromycin-sulfisoxazole and cefaclor in acute otitis media: a double blind randomized trial.
    Bergeron MG; Ahronheim G; Richard JE; Riding K; Cron C; Bryer D; Macdonald N; Bouchard M; Young J; Dempsey EE
    Pediatr Infect Dis J; 1987 Jul; 6(7):654-60. PubMed ID: 3302918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
    Liljequist BO; Gezelius L
    Eur J Clin Microbiol; 1986 Dec; 5(6):615-21. PubMed ID: 3492374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Haemophilus influenzae resistance and cefaclor].
    Cobo J; Sacristán JA; Hernández J
    Enferm Infecc Microbiol Clin; 1993 Nov; 11(9):512-5. PubMed ID: 8305565
    [No Abstract]   [Full Text] [Related]  

  • 28. Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclor.
    Galán JC; Morosini MI; Baquero MR; Reig M; Baquero F
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2551-7. PubMed ID: 12878518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of cefaclor and amoxycillin in the treatment of acute otitis media.
    Jacobson JA; Metcalf TJ; Parkin JL; Wenerstrom LG; Matsen JM
    Postgrad Med J; 1979; 55 Suppl 4():39-41. PubMed ID: 44907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species.
    Bulger RR; Washington JA
    Antimicrob Agents Chemother; 1980 Mar; 17(3):393-6. PubMed ID: 6448575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of cefprozil (BMY 28100) and cefepime (BMY 28142) against Streptococcus pneumoniae, Branhamella catarrhalis, and Haemophilus influenzae, and provisional interpretive criteria for disk diffusion and dilution susceptibility tests with Haemophilus influenzae.
    Doern GV; Vautour R
    Diagn Microbiol Infect Dis; 1992; 15(7):633-40. PubMed ID: 1424521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of ROB-1 beta-lactamase correlates with cefaclor resistance among recent isolates of Haemophilus influenzae.
    Karlowsky JA; Verma G; Zhanel GG; Hoban DJ
    J Antimicrob Chemother; 2000 Jun; 45(6):871-5. PubMed ID: 10837442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of BMY-28100, a new oral cephalosporin.
    Norden CW; Niederriter K
    Chemotherapy; 1988; 34(1):27-9. PubMed ID: 3258231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study.
    Doern GV; Jorgensen JH; Thornsberry C; Preston DA
    Diagn Microbiol Infect Dis; 1986 Feb; 4(2):95-107. PubMed ID: 3485505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of inoculum size on Haemophilus influenzae type b susceptibility to new and conventional antibiotics.
    Laferriere C; Marks MI; Welch DF
    Antimicrob Agents Chemother; 1983 Aug; 24(2):287-9. PubMed ID: 6605716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro bactericidal activity of four oral antibiotics against pathogens responsible for acute otitis media in children.
    Lambert-Zechovsky N; Mariani-Kurkdjian P; Doit C; Bourgeois F; Bingen E
    J Hosp Infect; 1992 Nov; 22 Suppl A():89-97. PubMed ID: 1362754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis of the efficacy of cefaclor against Haemophilus influenzae.
    Picard M; Malouin F
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2569-72. PubMed ID: 1489208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity and beta-lactamase stability of the oral cephalosporin BMY-28100.
    Hiraoka M; Masuyoshi S; Tomatsu K; Inoue M; Mitsuhashi S
    Eur J Clin Microbiol; 1987 Oct; 6(5):559-63. PubMed ID: 3501756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative activities of moxalactam (LY 127935) a new semisynthetic 1-oxa-beta lactam antibiotic with 7 other antibiotics against type b Haemophilus influenzae.
    Chu ML; Harms JL; Liu C
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1981 Sep; 14(3):146-55. PubMed ID: 6456875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative activity of oral beta-lactam antibiotics against fifty strains of Haemophilus influenzae producing a beta-lactamase according to bacterial inoculum].
    Gaillot O; Simonet M
    Pathol Biol (Paris); 1994 May; 42(5):375-7. PubMed ID: 7824299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.